Bortezomib injection is used for treating multiple myeloma (blood plasma cell cancer) in patients with or without a previous history of treatment, and mantle cell lymphoma. Bortezomib is an antineoplastic agent (cancer medication).

It intermeddles with the growth of cancer cells, which are ultimately destroyed by the body. Since the growth of normal body cells might also be affected by bortezomib, other effects will also happen. Some of these might be severe and must be reported to your doctor.

Other effects, like a skin rash, might not be severe but may cause concern. Some effects might not happen until months or years after the medicine is used. The medication is to be administered only by or under the immediate supervision of your doctor.

The product is available in the following dosing forms:

1. Powder for Solution
2. Solution